Valuation: Inter Pharma

Market Cap 296.62Cr 8.75Cr 7.93Cr 7.34Cr 6.62Cr 12Cr 825.35Cr 13Cr 88Cr 35Cr 440.88Cr 33Cr 32Cr 1.4TCr P/E 2024
52.3x
P/E 2025 22.8x
Enterprise Value 308.55Cr 9.11Cr 8.25Cr 7.63Cr 6.89Cr 13Cr 858.54Cr 13Cr 92Cr 36Cr 458.61Cr 34Cr 33Cr 1.46TCr EV / Sales 2024
1.13x
EV / Sales 2025 1.31x
Free-Float
-
Yield 2024 *
-
Yield 2025 1.59%
02/11 Inter Pharma Public Company Limited Announces Resignation of Yuttana Suwannachot as Director, Effective October 31, 2026 CI
07/10 Inter Pharma Public Company Limited Announces Board and Committee Changes CI
14/08 Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
11/05 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02/03 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02/03 Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026 CI
12/11 Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients. CI
12/11 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/25/14 Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
13/25/13 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/25/16 Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal MT
16/25/16 Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited CI
01/25/01 Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation CI
1 day-0.41%
1 week+1.66%
Current month+1.24%
1 month+0.82%
3 months-10.91%
6 months+17.79%
Current year+6.52%
1 week 4.8
Extreme 4.8
4.96
1 month 4.8
Extreme 4.8
5.05
Current year 3.68
Extreme 3.68
5.65
1 year 3.68
Extreme 3.68
5.65
3 years 2.02
Extreme 2.02
7.3
5 years 2.02
Extreme 2.02
14.09
10 years 1.62
Extreme 1.617581
15.14
Manager TitleAgeSince
Chief Executive Officer 56 01/02/2014
Director of Finance/CFO 56 23/06/2023
Compliance Officer 54 -
Director TitleAgeSince
Director/Board Member 51 14/06/2017
Director/Board Member 64 01/08/2020
Director/Board Member 56 01/02/2014
Date Insider Type Main position Quantity % Market Cap. Importance
21/05/26 Buy

Chief Executive Officer

60,000 0.0099%
21/05/26 Buy

Chief Executive Officer

60,000 0.0099%
20/05/26 Buy

Chief Executive Officer

22,600 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
-0.41%+1.66%+22.50%-12.02% 8.75Cr
+1.26%+6.61%+40.79%+136.32% 1,28600Cr
+0.79%+3.45%+45.84%+93.52% 69TCr
+0.20%+1.28%+26.97%+113.70% 52TCr
-0.44%+3.69%+41.45%+68.91% 39TCr
+0.55%+0.70%+59.02%+44.62% 36TCr
-0.12%+0.74%+28.39%+58.54% 30TCr
+0.37%+0.37%+3.33%+37.27% 29TCr
-0.30%+1.14%+38.29%+72.46% 25TCr
+0.08%+0.71%+34.44%+124.95% 21TCr
Average +0.20%+1.95%+34.10%+73.83% 43TCr
Weighted average by Cap. +0.54%+3.26%+37.70%+96.50%

Financials

2024 2025
Net sales 191.19Cr 5.64Cr 5.11Cr 4.73Cr 4.27Cr 8.04Cr 532Cr 8.32Cr 57Cr 23Cr 284.18Cr 21Cr 21Cr 902.08Cr 221.41Cr 6.53Cr 5.92Cr 5.48Cr 4.94Cr 9.31Cr 616.07Cr 9.64Cr 66Cr 26Cr 329.09Cr 25Cr 24Cr 1.04TCr
Net income 3.73Cr 11L 10L 9L 8L 15.68L 10Cr 16.23L 1.11Cr 43.92L 5.54Cr 41.28L 40.41L 18Cr 12Cr 36.12L 32.73L 30.27L 27.31L 51.47L 34Cr 53.28L 3.64Cr 1.44Cr 18Cr 1.36Cr 1.33Cr 58Cr
Net Debt 21Cr 61.65L 55.87L 51.68L 46.62L 87.87L 58Cr 90.96L 6.21Cr 2.46Cr 31Cr 2.31Cr 2.26Cr 99Cr 12Cr 35.2L 31.9L 29.51L 26.62L 50.17L 33Cr 51.94L 3.54Cr 1.41Cr 18Cr 1.32Cr 1.29Cr 56Cr
Projected Income Statement - Annual - Inter Pharma
Logo Inter Pharma
Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.
Employees
-
Date Price Change Volume
13/26/13 THB 4.900 -0.41% 90,154
12/26/12 THB 4.920 +0.41% 1,10,120
11/26/11 THB 4.900 +0.82% 47,517
10/26/10 THB 4.860 0.00% 94,712
09/26/09 THB 4.860 +0.83% 2,34,728

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Inter Pharma